WallStreetZenWallStreetZen

NYSE: MDT
Medtronic PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MDT

Based on 17 analysts offering 12 month price targets for Medtronic PLC

Min Forecast
$83.00-14.03%
Avg Forecast
$103.59+7.3%
Max Forecast
$118.00+22.23%

Should I buy or sell MDT stock?

Based on 17 analysts offering ratings for Medtronic PLC.

Buy
Strong Buy
5 analysts 29.41%
Buy
7 analysts 41.18%
Hold
5 analysts 29.41%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MDT's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates MDT as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their MDT stock forecasts and price targets.

MDT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-10-12
lockedlocked$00.00+00.00%2026-10-07
lockedlocked$00.00+00.00%2026-09-30
lockedlocked$00.00+00.00%2026-09-03
lockedlocked$00.00+00.00%2026-09-02
Wells Fargo
Top 10%
91
Strong BuyMaintains$104.00+7.73%2026-09-02
RBC Capital
Bottom 19%
19
BuyReiterates$118.00+22.23%2026-09-02
Bank of America
Bottom 1%
1
Strong BuyMaintains$110.00+13.94%2026-09-02
Stifel Nicolaus
Top 12%
89
HoldMaintains$95.00-1.60%2026-09-02
Baird
Top 15%
86
HoldMaintains$100.00+3.58%2026-09-02

1 of 2

Forecast return on equity

Is MDT forecast to generate an efficient return?

Company
17.76%
Industry
13.2%
Market
171.95%
MDT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MDT forecast to generate an efficient return on assets?

Company
9.56%
Industry
13.59%
MDT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MDT earnings per share forecast

What is MDT's earnings per share in the next 3 years based on estimates from 33 analysts?

Avg 1 year Forecast
$6.04+47.61%
Avg 2 year Forecast
$6.45+57.81%
Avg 3 year Forecast
$6.98+70.63%
MDT's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

MDT revenue forecast

What is MDT's revenue in the next 3 years based on estimates from 32 analysts?

Avg 1 year Forecast
$39.5B+5.09%
Avg 2 year Forecast
$40.7B+8.48%
Avg 3 year Forecast
$42.8B+13.91%
MDT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MDT earnings growth forecast

How is MDT forecast to perform vs Medical Devices companies and vs the US market?

Company
19.32%
Industry
21.8%
Market
32.44%
MDT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
MDT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
MDT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

MDT revenue growth forecast

How is MDT forecast to perform vs Medical Devices companies and vs the US market?

Company
4.26%
Industry
6.9%
Market
12.61%
MDT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MDT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MDT vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
MDT$96.54$103.59+7.30%Buy
SYK$291.86$352.06+20.62%Strong Buy
ABT$106.20$122.27+15.13%Strong Buy
BSX$41.98$55.95+33.28%Buy
EW$92.01$105.08+14.21%Strong Buy
View Top Medical Device Stocks

Medtronic Stock Forecast FAQ

Is Medtronic Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 17 Wall Street analysts covering (NYSE: MDT) stock is to Buy MDT stock.

Out of 17 analysts, 5 (29.41%) are recommending MDT as a Strong Buy, 7 (41.18%) are recommending MDT as a Buy, 5 (29.41%) are recommending MDT as a Hold, 0 (0%) are recommending MDT as a Sell, and 0 (0%) are recommending MDT as a Strong Sell.

If you're new to stock investing, here's how to buy Medtronic stock.

What is MDT's earnings growth forecast for 2027-2029?

(NYSE: MDT) Medtronic's forecast annual earnings growth rate of 19.32% is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 21.8%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.44%.

Medtronic's earnings in 2026 is $5,231,000,000.On average, 33 Wall Street analysts forecast MDT's earnings for 2027 to be $7,722,283,356, with the lowest MDT earnings forecast at $7,459,932,174, and the highest MDT earnings forecast at $8,085,430,603. On average, 33 Wall Street analysts forecast MDT's earnings for 2028 to be $8,256,067,597, with the lowest MDT earnings forecast at $7,822,184,025, and the highest MDT earnings forecast at $8,824,132,734.

In 2029, MDT is forecast to generate $8,926,591,679 in earnings, with the lowest earnings forecast at $8,297,127,923 and the highest earnings forecast at $9,616,558,657.

What is MDT's revenue growth forecast for 2027-2029?

(NYSE: MDT) Medtronic's forecast annual revenue growth rate of 4.26% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.61%.

Medtronic's revenue in 2026 is $37,541,000,000.On average, 32 Wall Street analysts forecast MDT's revenue for 2027 to be $50,464,548,036,280, with the lowest MDT revenue forecast at $48,721,083,092,210, and the highest MDT revenue forecast at $52,704,318,481,670. On average, 32 Wall Street analysts forecast MDT's revenue for 2028 to be $52,091,611,432,360, with the lowest MDT revenue forecast at $46,213,972,827,810, and the highest MDT revenue forecast at $55,546,562,873,250.

In 2029, MDT is forecast to generate $54,699,773,590,070 in revenue, with the lowest revenue forecast at $48,829,809,812,860 and the highest revenue forecast at $58,860,809,146,240.

What is MDT's forecast return on assets (ROA) for 2027-2029?

(NYSE: MDT) forecast ROA is 9.56%, which is lower than the forecast US Medical Devices industry average of 13.59%.

What is MDT's Price Target?

According to 17 Wall Street analysts that have issued a 1 year MDT price target, the average MDT price target is $103.59, with the highest MDT stock price forecast at $118.00 and the lowest MDT stock price forecast at $83.00.

On average, Wall Street analysts predict that Medtronic's share price could reach $103.59 by Oct 12, 2027. The average Medtronic stock price prediction forecasts a potential upside of 7.3% from the current MDT share price of $96.54.

What is MDT's Earnings Per Share (EPS) forecast for 2027-2029?

(NYSE: MDT) Medtronic's current Earnings Per Share (EPS) is $4.09. On average, analysts forecast that MDT's EPS will be $6.04 for 2027, with the lowest EPS forecast at $5.83, and the highest EPS forecast at $6.32. On average, analysts forecast that MDT's EPS will be $6.45 for 2028, with the lowest EPS forecast at $6.12, and the highest EPS forecast at $6.90. In 2029, MDT's EPS is forecast to hit $6.98 (min: $6.49, max: $7.52).

What is MDT's forecast return on equity (ROE) for 2027-2029?

(NYSE: MDT) forecast ROE is 17.76%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.